Next Article In Issue>
Volume 8, Issue 3-4, December 2018, Pages 103 - 105
New TB Tools Need to be Affordable in the Private Sector: The Case Study of Xpert MTB/RIF
Authors
Nirros Ponnudurai
Faculty of Medicine, McGill University, Montreal, Canada
Claudia M. Denkinger
Foundation for Innovative New Diagnostics, Geneva, Switzerland
Wayne Van Gemert
Global Drug Facility, Stop TB Partnership, Geneva, Switzerland
Madhukar Pai*
McGill International TB Centre, McGill University, Montreal, Canada
Manipal McGill Centre for Infectious Diseases, Manipal Academy of Higher Education, Manipal, India
* Address: McGill University, Dept of Epidemiology & Biostatistics, 1020 Pine Ave West, Montreal, QC H3A 1A2, Canada. E-mail address: madhukar.pai@mcgill.ca
Corresponding Author
Madhukar Pai
Received 24 April 2018, Accepted 25 April 2018, Available Online 31 December 2018.
- DOI
- 10.2991/j.jegh.2018.04.005How to use a DOI?
- Copyright
- © 2018 Atlantis Press International B.V.
- Open Access
- This is an open access article under the CC BY-NC license (http://creativecommons.org/licences/by-nc/4.0/).
Download article (PDF)
View full text (HTML)
Next Article In Issue>
Cite this article
TY - JOUR AU - Nirros Ponnudurai AU - Claudia M. Denkinger AU - Wayne Van Gemert AU - Madhukar Pai PY - 2018 DA - 2018/12/31 TI - New TB Tools Need to be Affordable in the Private Sector: The Case Study of Xpert MTB/RIF JO - Journal of Epidemiology and Global Health SP - 103 EP - 105 VL - 8 IS - 3-4 SN - 2210-6014 UR - https://doi.org/10.2991/j.jegh.2018.04.005 DO - 10.2991/j.jegh.2018.04.005 ID - Ponnudurai2018 ER -